Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Thermo Fisher Scientific Opens U.S. Flagship Bioprocess Design Center to Accelerate the Delivery of Life-changing Therapies
Wednesday, April 29, 2026Thermo Fisher Scientific Inc the world leader in serving science today announced the opening of its flagship US Bioprocess Design Center BDC at the companys Plainville Mass site expanding the facility to support customers
AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid
Tuesday, April 28, 2026AviadoBio Ltd and Apertura Gene Therapy Apertura a biotechnology company developing nextgeneration AAV capsids for delivering genetic medicines today announced a licensing agreement for Aperturas TfR CapX
Prothena Announces Novo Nordisk Obtains Fast Track Designation from the U.S. FDA for Coramitug (PRX004) in ATTR Amyloidosis with Cardiomyopathy
Tuesday, April 28, 2026Prothena Corporation plc NASDAQPRTA today announced that the US Food and Drug Administration FDA has granted Fast Track Designation to coramitug a potential bestinclass amyloid depleter antibody currently in Phase
Digital Health’s Leading Voices to Convene at HIMSS26 Europe in Copenhagen
Friday, April 24, 2026The HIMSS European Health Conference Exhibition will bring together leading voices in digital health from May in Copenhagen Denmark As one of the premier gatherings for healthcare innovation
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
Friday, April 24, 2026Alloy Therapeutics a leading biotechnology ecosystem company today announced a strategic collaboration with the Institute for Protein Innovation IPI a nonprofit leader in protein engineering
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
Thursday, April 23, 2026BioMedWire Editorial Coverage The biotechnology industry is experiencing a subtle yet meaningful transformation that is redefining how value is interpreted within a sector long associated with extended development cycles
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
Wednesday, April 22, 2026Roche announced today new data from the positive Phase III FENhance and studies which met their primary endpoint The studies showed that fenebrutinib an investigational noncovalent Brutons tyrosine kinase
Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
Wednesday, April 22, 2026The US Food and Drug Administration FDA has approved the supplemental biologic license application for Tzield teplizumabmzwv expanding the indication from eight years and older to as young as one year of age
Argo Biopharma Doses First Patients in Phase II Clinical Trials of siRNA Therapy BW-40202
Tuesday, April 21, 2026Argo Biopharmaceutical Co Ltd Argo Biopharma a clinicalstage small interfering RNA siRNA therapeutics company today announced the first patient has been dosed in multiple Phase II studies of BW
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
Tuesday, April 21, 2026Boehringer Ingelheim today announced the expansion of its global Computational Innovation footprint with the launch of a new center for AI and machine learning in Kings Cross London UK part of the Knowledge
